Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients.

作者: Kazuomi Kario , Yuichirou Yano , Takefumi Matsuo , Satoshi Hoshide , Kazuo Eguchi

DOI: 10.1093/EURHEARTJ/EHQ444

关键词:

摘要: Aims Stroke events occur most frequently in the morning hours. Impaired haemostatic activity and blood pressure (BP) surge, defined as BP increase from sleep, have individually been associated with stroke risk general or hypertensive populations. However, their combined impact on of a remains unknown. Methods results A total 514 patients aged >50 years (mean 72.3 years; 37%men) underwent 24 h monitoring, measurement factors [plasma fibrinogen, plasminogen activator inhibitor-1 (PAI-1), prothrombin fragment 1+2(F1+2)], brain MRI at baseline. The incidence was prospectively ascertained. During an average 41 months (1751 person-years), there were 43 (ischaemic, 30; haemorrhagic, 5; undefined, 8). On multivariable analysis adjusted for confounding factors, hazard ratio [HR (95% confidence interval (CI)] highest vs. lower quartiles PAI-1 2.5 (1.3–4.6), that F1+2 2.6 (1.4–5.0), surge 1.2 (1.1–1.4; all P < 0.01). In particular, substantially higher cases quartile both levels compared those parameters (HR: 8.2; 95% CI: 3.7–18.2; 0.001). Among ( n = 128), HR CI) 3.4 (1.3–9.1) 3.3 (1.3–8.7) (both 0.05). Conclusion High plasma F1+2, well excessive are independently additively increased older patients.

参考文章(26)
P Angleton, W L Chandler, G Schmer, Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. ,vol. 79, pp. 101- 106 ,(1989) , 10.1161/01.CIR.79.1.101
C. E. Hafer-Macko, F. M. Ivey, J. D. Sorkin, R. F. Macko, Microvascular tissue plasminogen activator is reduced in diabetic neuropathy Neurology. ,vol. 69, pp. 268- 274 ,(2007) , 10.1212/01.WNL.0000266391.20707.83
Encarna García, Frank Leebeek, Geert-Jan Brouwers, Peter Koudstaal, Diederik Dippel, Mary-Lou Goor, The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. Thrombosis and Haemostasis. ,vol. 93, pp. 92- 96 ,(2004) , 10.1160/TH04-09-0560
Peter M. Rothwell, Sally C. Howard, Dermot A. Power, Sergei A. Gutnikov, Ale Algra, Jan van Gijn, Tanne G. Clark, Michael F.G. Murphy, Charles P. Warlow, Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke Stroke. ,vol. 35, pp. 2300- 2305 ,(2004) , 10.1161/01.STR.0000141701.36371.D1
Stylianos Kapiotis, Bernd Jilma, Peter Quehenberger, Katharina Ruzicka, Sylvia Handler, Wolfgang Speiser, Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex Circulation. ,vol. 96, pp. 19- 21 ,(1997) , 10.1161/01.CIR.96.1.19
Philippe Gosse, Rapha??l Lasserre, Catherine Minifi??, Philippe Lemetayer, Jacques Clementy, Blood pressure surge on rising. Journal of Hypertension. ,vol. 22, pp. 1113- 1118 ,(2004) , 10.1097/00004872-200406000-00011
Aaron R. Folsom, Wayne D. Rosamond, Eyal Shahar, Lawton S. Cooper, Nena Aleksic, F. Javier Nieto, Mandy L. Rasmussen, Kenneth K. Wu, Prospective Study of Markers of Hemostatic Function With Risk of Ischemic Stroke Circulation. ,vol. 100, pp. 736- 742 ,(1999) , 10.1161/01.CIR.100.7.736
Robert Côté, Christina Wolfson, Susan Solymoss, Ariane Mackey, Jacques R Leclerc, Denis Simard, Fabrice Rouah, France Bourque, Barbara Léger, Hemostatic Markers in Patients at Risk of Cerebral Ischemia Stroke. ,vol. 31, pp. 1856- 1862 ,(2000) , 10.1161/01.STR.31.8.1856